{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:38:35Z","timestamp":1769557115128,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPQ","doi-asserted-by":"publisher","award":["Universal 479417\/2008 3"],"award-info":[{"award-number":["Universal 479417\/2008 3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01AI079238A"],"award-info":[{"award-number":["R01AI079238A"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.actatropica.2016.12.030","type":"journal-article","created":{"date-parts":[[2016,12,28]],"date-time":"2016-12-28T13:01:42Z","timestamp":1482930102000},"page":"157-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Schistosoma antigens downregulate CXCL9 production by PBMC of HTLV-1-infected individuals"],"prefix":"10.1016","volume":"167","author":[{"given":"Luciane Mota","family":"Lima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Santos","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvane Braga","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo Riccio","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9rgio Costa","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo Miranda","family":"G\u00f3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Loukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Ilma","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2016.12.030_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0022-510X(96)00025-1","article-title":"Immunological features of HTLV-I myelopathy in Rio de Janeiro, Brazil, and in vitro effects of cyclosporin A","volume":"139","author":"Andrada-Serpa","year":"1996","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.actatropica.2016.12.030_bib0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-0404.1993.tb04188.x","article-title":"Clinical and demographic features of HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Rio de Janeiro, Brazil","volume":"88","author":"Ara\u00fajo Ade","year":"1993","journal-title":"Acta. Neurol. Scand."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1600-0625.2006.00431.x","article-title":"Prevention of psoriasis-like lesions development in fsn\/fsn mice by helminth glycans","volume":"158","author":"Atochina","year":"2006","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2249.2006.03252.x","article-title":"IL-10 produced by CD4+ and CD8+ T cell emerge as a putative immunoregulatory mechanism to counter-balance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical satatus durin chronic HTLV-1 infection","volume":"147","author":"Britto-Melo","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0025","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1128\/IAI.01005-09","article-title":"Impairment of gamma interferon signaling in human neutrophils infected with Anaplasma phagocytophilum","volume":"1","author":"Bussmeyer","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0030","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2249.2006.03081.x","article-title":"Human antibody responses of patients living in endemic areas for Schistosomiasis to the Tegumental protein Sm29 identified through genomic studies","volume":"144","author":"Cardoso","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2859-6-1","article-title":"Polymyxin b as inhibitor of lps contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis","volume":"6","author":"Cardoso","year":"2007","journal-title":"Microb. Cell. Fact."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0040","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1590\/S0037-86822002000500013","article-title":"Infection and disease caused by the human T cell lymphotropic viruses type I and II in Brazil","volume":"35","author":"Carneiro-Proietti","year":"2002","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00126334-200105010-00001","article-title":"Cytokine profile and immunomodulation in asymptomatic human T- lymphotropic virus type 1-infected blood donors","volume":"27","author":"Carvalho","year":"2001","journal-title":"J. Acquir. Immune. Defic. Syndr."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/aid.2006.0140","article-title":"Clinical manifestations associated with HTLV type I infection: a cross-sectional study","volume":"23","author":"Caskey","year":"2007","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.actatropica.2016.12.030_bib0055","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/sj.ijir.3901335","article-title":"Erectile dysfunction and HTLV-1 infection: a silent problem","volume":"17","author":"Castro","year":"2005","journal-title":"Int. J. Impot. Res."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0060","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.urology.2007.01.052","article-title":"Urinary symptoms associated with human T-cell lymphotropic virus type I infection: evidence of urinary manifestations in large group of HTLV-I carriers","volume":"69","author":"Castro","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.actatropica.2016.12.030_bib0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-3024.1999.00213.x","article-title":"Infection with Schistosoma mansoni prevents insulin dependent diabetis mellitus in non-obese diabetic mice","volume":"21","author":"Cooke","year":"1999","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0070","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/ard.51.6.769","article-title":"Primary Sjogren\u2019s syndrome with antibodies to HTLV-I: clinical and laboratory features","volume":"51","author":"Eguchi","year":"1992","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0075","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2249.2006.03150.x","article-title":"Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-I)\/tropical spastic paraparesis (HAM\/TSP) disease from HTLV-I carrier state","volume":"145","author":"Guerreiro","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1017\/S0031182000066105","article-title":"Characterization of fractionated Schistosoma mansoni soluble adult worm antigens that elicit human cell proliferation and granuloma formation in vitro","volume":"112","author":"Hirsch","year":"1996","journal-title":"Parasitology"},{"issue":"2","key":"10.1016\/j.actatropica.2016.12.030_bib0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jss.2008.04.015","article-title":"Inhibition of the Kupffer cell and neutralization of IL-10 increase the expression of chemokines in the lung in a rat peritonitis model","volume":"150","author":"Kono","year":"2008","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0090","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jnnp.2004.035709","article-title":"Gender influence on the progression of HTLV-I associated myelopathy\/tropical spastic paraparesis","volume":"76","author":"Lima","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.actatropica.2016.12.030_bib0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000348700","article-title":"Schistosoma antigens downmodulate the in vitro inflammatory response in individuals infected with Human T cells lymphotropic virus type 1","volume":"20","author":"Lima","year":"2013","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.actatropica.2016.12.030_bib0100","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2990.2010.01089.x","article-title":"Review: the chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity-a tale of conflict and conundrum","volume":"36","author":"M\u00fcller","year":"2010","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0105","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/0140-6736(92)90699-4","article-title":"HTLV-I and uveitis","volume":"339","author":"Mochizuki","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2016.12.030_bib0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jneuroim.2007.05.015","article-title":"High production of RANTES and MIP-1alpha in the tropical spastic paraparesis\/HTLV-I-associated myelopathy (TSP\/HAM)","volume":"188","author":"Montanheiro","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0115","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0140-6736(89)91793-5","article-title":"HTLV-I and polymyositis in Jamaica","volume":"2","author":"Morgan","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2016.12.030_bib0120","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00019052-200106000-00019","article-title":"Immunopathogenesis of human T cell lymphotropic virus type I-associated myelopathy","volume":"14","author":"Nagai","year":"2001","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jneuroim.2004.10.011","article-title":"CSF-chemokines in HTLVI-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha","volume":"159","author":"Narikawa","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0022-510X(90)90217-B","article-title":"Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy\/tropical spastic paraparesis","volume":"97","author":"Nishimoto","year":"1990","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0135","series-title":"Efeito do glucuronoxilomanana (GXM) obtida do Cryptococus neoformans e do Cryptococus gattii sobre a resposta de celulas mononucleares humanas ao IFN-\u03b3.Disserta\u00e7\u00e3o de Mestrado","first-page":"104","author":"Nogueira","year":"2012"},{"key":"10.1016\/j.actatropica.2016.12.030_bib0140","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1212\/WNL.41.4.594","article-title":"Interleukin-6 in cerebrospinal fluid of HTLV-I-associated myelopathy","volume":"41","author":"Ohbo","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.actatropica.2016.12.030_bib0145","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-1 associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2016.12.030_bib0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri843","article-title":"The immunobiology of schistosomiasis","volume":"7","author":"Pearce","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0155","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1086\/427560","article-title":"Helminthic infection dow-Regulates type 1 immune responses in human t cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalet in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"191","author":"Porto","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2334-4-7","article-title":"Exacerbated inflammatory cellular Immune response characteristics of HAM\/TSP is observed in a large proportion of HTLV-1 asymptomatic carriers","volume":"4","author":"Santos","year":"2004","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0165","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1371\/journal.pntd.0002479","article-title":"CSF, CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"7","author":"Sato","year":"2013","journal-title":"PLOS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0170","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nri821","article-title":"CD4+CD25+ suppressor T cells: more questions than answers","volume":"2","author":"Shevach","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0175","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1590\/S0100-879X1999000900008","article-title":"Detection of specific IgE antibodies in parasite diseases","volume":"32","author":"Souza-Atta","year":"1999","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0180","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nm1430","article-title":"Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis","volume":"7","author":"Tran","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0185","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/oxfordjournals.molbev.a003846","article-title":"Dating the origin of the African human T-Cell lymphotropic virus type-1 (HTLV-1) subtypes","volume":"18","author":"Van Dooren","year":"2001","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0190","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev.immunol.19.1.475","article-title":"Multiple viral strategies of HTLV-1 for dysregulation of cell growth control","volume":"19","author":"Yoshida","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.actatropica.2016.12.030_bib0195","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1212\/WNL.53.2.386","article-title":"Quantitative assessment of subclinical spasticity in human T-cell lymphotropic virus type I infection","volume":"53","author":"Zunt","year":"1999","journal-title":"Neurology"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X16311421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X16311421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T09:22:45Z","timestamp":1536139365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X16311421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":39,"alternative-id":["S0001706X16311421"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2016.12.030","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Schistosoma antigens downregulate CXCL9 production by PBMC of HTLV-1-infected individuals","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2016.12.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}